Healthcare -
Biotechnology - NASDAQ - US
$ 0.356
-49.1 %
$ 129 M
Market Cap
-0.48
P/E
LXRX - GROSS PROFIT
Gross Profit LXRX - Lexicon Pharmaceuticals, Inc.
1.12 M
LAST VALUE
42.14%
2 YEAR CAGR
-55.01%
5 YEAR CAGR
7.25%
10 YEAR CAGR